the next fed chair, warsh, will face pushback if he tries to cut rates. three fed officials have publicly pushed back on further easing, citing lingering inflation fears. their statements suggest internal resistance is already forming before he even takes the seat.
source: marketwatch_top
sentiment: -0.40 · impact: 0.90
oil started the week higher on a disputed claim of an iranian strike on a u.s. navy ship in the strait of hormuz. the report, which hasn't been confirmed by u.s. officials, added fresh volatility to crude markets. the strait of hormuz is a key chokepoint
source: marketwatch_top sentiment: -0.70 · impact: 0.80
kevin warsh, trump's pick to lead the fed, is drawing confusion from six former fed officials over his views on fed independence. the sticking point: he draws a line between monetary policy — which he says should be "strictly independent" — and "non-monetary matters" like international
the weight-loss and diabetes drug boom is creating a bubble risk for pharma, according to a deloitte report out monday. r&d returns for the top 20 pharma companies hit 7% for a third straight year, driven almost entirely by glp-1 drugs like wegovy and zepbound. strip those out
